Cidara Therapeutics (CDTX) Competitors $65.62 +0.75 (+1.16%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$65.63 +0.01 (+0.02%) As of 09/12/2025 06:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CDTX vs. LEGN, ABVX, AXSM, RNA, NUVL, MRUS, CRSP, TGTX, ACAD, and KRYSShould you be buying Cidara Therapeutics stock or one of its competitors? The main competitors of Cidara Therapeutics include Legend Biotech (LEGN), Abivax (ABVX), Axsome Therapeutics (AXSM), Avidity Biosciences (RNA), Nuvalent (NUVL), Merus (MRUS), CRISPR Therapeutics (CRSP), TG Therapeutics (TGTX), ACADIA Pharmaceuticals (ACAD), and Krystal Biotech (KRYS). These companies are all part of the "pharmaceutical products" industry. Cidara Therapeutics vs. Its Competitors Legend Biotech Abivax Axsome Therapeutics Avidity Biosciences Nuvalent Merus CRISPR Therapeutics TG Therapeutics ACADIA Pharmaceuticals Krystal Biotech Cidara Therapeutics (NASDAQ:CDTX) and Legend Biotech (NASDAQ:LEGN) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, valuation, institutional ownership, media sentiment and earnings. Do analysts rate CDTX or LEGN? Cidara Therapeutics presently has a consensus price target of $64.14, suggesting a potential downside of 2.25%. Legend Biotech has a consensus price target of $74.22, suggesting a potential upside of 124.17%. Given Legend Biotech's higher possible upside, analysts plainly believe Legend Biotech is more favorable than Cidara Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cidara Therapeutics 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.11Legend Biotech 0 Sell rating(s) 1 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.91 Do insiders and institutionals hold more shares of CDTX or LEGN? 35.8% of Cidara Therapeutics shares are owned by institutional investors. Comparatively, 70.9% of Legend Biotech shares are owned by institutional investors. 3.9% of Cidara Therapeutics shares are owned by company insiders. Comparatively, 0.0% of Legend Biotech shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Is CDTX or LEGN more profitable? Cidara Therapeutics has a net margin of 0.00% compared to Legend Biotech's net margin of -40.83%. Legend Biotech's return on equity of -32.00% beat Cidara Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Cidara TherapeuticsN/A -50.81% -42.46% Legend Biotech -40.83%-32.00%-20.07% Which has more volatility & risk, CDTX or LEGN? Cidara Therapeutics has a beta of 1.29, suggesting that its share price is 29% more volatile than the S&P 500. Comparatively, Legend Biotech has a beta of 0.28, suggesting that its share price is 72% less volatile than the S&P 500. Which has higher earnings and valuation, CDTX or LEGN? Cidara Therapeutics has higher earnings, but lower revenue than Legend Biotech. Legend Biotech is trading at a lower price-to-earnings ratio than Cidara Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCidara Therapeutics$1.27M1,310.33-$169.83M-$11.13-5.90Legend Biotech$627.24M9.74-$177.03M-$0.88-37.63 Does the media refer more to CDTX or LEGN? In the previous week, Cidara Therapeutics and Cidara Therapeutics both had 6 articles in the media. Cidara Therapeutics' average media sentiment score of 1.42 beat Legend Biotech's score of 1.30 indicating that Cidara Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cidara Therapeutics 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Legend Biotech 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryCidara Therapeutics beats Legend Biotech on 9 of the 16 factors compared between the two stocks. Get Cidara Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CDTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CDTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDTX vs. The Competition Export to ExcelMetricCidara TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.64B$3.20B$5.87B$10.13BDividend YieldN/A2.30%5.68%4.60%P/E Ratio-5.9021.1774.5225.93Price / Sales1,310.33427.59516.43181.21Price / CashN/A46.6837.5660.44Price / Book4.409.6112.166.29Net Income-$169.83M-$53.29M$3.28B$270.77M7 Day Performance3.88%0.12%0.78%3.84%1 Month Performance3.75%5.60%4.87%4.85%1 Year Performance449.58%10.47%60.72%26.00% Cidara Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDTXCidara Therapeutics3.281 of 5 stars$65.62+1.2%$64.14-2.3%+478.1%$1.64B$1.27M-5.9090Positive NewsLEGNLegend Biotech3.2636 of 5 stars$34.73+1.0%$74.22+113.7%-34.7%$6.41B$627.24M-39.472,609Positive NewsABVXAbivax2.5907 of 5 stars$81.03-0.7%$92.33+13.9%+602.4%$6.12BN/A0.0061News CoverageEarnings ReportAnalyst ForecastShort Interest ↑Gap DownAXSMAxsome Therapeutics4.9166 of 5 stars$121.28-0.4%$178.00+46.8%+29.1%$6.05B$385.69M-23.92380Positive NewsInsider TradeRNAAvidity Biosciences2.1395 of 5 stars$46.58-4.1%$67.00+43.8%+8.3%$5.99B$10.90M-13.08190Trending NewsAnalyst ForecastInsider TradeGap UpNUVLNuvalent2.9982 of 5 stars$76.58+0.7%$120.80+57.7%-1.5%$5.52BN/A-15.6340Insider TradeMRUSMerus3.076 of 5 stars$65.84-0.4%$88.75+34.8%+41.6%$4.98B$36.13M-11.9737Positive NewsCRSPCRISPR Therapeutics3.4272 of 5 stars$51.83-2.3%$71.60+38.1%+22.6%$4.71B$37.31M-9.55460News CoverageTGTXTG Therapeutics4.149 of 5 stars$29.33+1.3%$46.25+57.7%+38.7%$4.65B$329M79.27290Positive NewsInsider TradeACADACADIA Pharmaceuticals4.3786 of 5 stars$25.99-0.9%$28.88+11.1%+48.0%$4.38B$957.80M19.54510News CoverageAnalyst ForecastKRYSKrystal Biotech4.9492 of 5 stars$147.70-2.0%$210.38+42.4%-26.6%$4.27B$290.52M30.02210Positive News Related Companies and Tools Related Companies Legend Biotech Competitors Abivax Competitors Axsome Therapeutics Competitors Avidity Biosciences Competitors Nuvalent Competitors Merus Competitors CRISPR Therapeutics Competitors TG Therapeutics Competitors ACADIA Pharmaceuticals Competitors Krystal Biotech Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CDTX) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cidara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cidara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDTX Stock Alerts